FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it
I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised […]
FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »